ORAL HGH Trademark

Trademark Overview

On Friday, August 20, 2021, a trademark application was filed for ORAL HGH with the United States Patent and Trademark Office. The USPTO has given the ORAL HGH trademark a serial number of 90893374. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 15, 2023. This trademark is owned by Sapphire Healthcare, LLC. The ORAL HGH trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements
oral hgh

General Information

Serial Number90893374
Word MarkORAL HGH
Filing DateFriday, August 20, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesNutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 7, 2021
Primary Code005
First Use Anywhere DateWednesday, September 21, 2022
First Use In Commerce DateWednesday, September 21, 2022

Trademark Owner History

Party NameSapphire Healthcare, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33131

Trademark Events

Event DateEvent Description
Tuesday, May 16, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 15, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, May 15, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 27, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, October 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, October 26, 2022USE AMENDMENT ACCEPTED
Thursday, October 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 4, 2022ASSIGNED TO EXAMINER
Friday, September 23, 2022AMENDMENT TO USE PROCESSING COMPLETE
Friday, September 23, 2022USE AMENDMENT FILED
Thursday, September 22, 2022TEAS AMENDMENT OF USE RECEIVED
Thursday, September 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 24, 2021NEW APPLICATION ENTERED

Related Keywords

oral supplements nutritional